Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global cardiac biomarkers market 360° synopsis, 2018 – 2032
2.2 Regional trends
2.3 Product trends
2.4 Application trends
2.5 End-use trends
Chapter 3 Cardiac Biomarkers Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Increase in prevalence of cardiovascular diseases
3.5.1.2 Rise in the elderly population is leading to a higher prevalence of heart-related conditions
3.5.1.3 Rising clinical research studies aimed at discovering new cardiac biomarkers
3.5.1.4 Increase in point-of-care testing
3.5.2 Industry pitfalls & challenges
3.5.2.1 Stringent regulatory frameworks
3.5.2.2 Presence and advancement in cardiac imaging technologies
3.6 Growth potential analysis
3.6.1 By product
3.6.2 By application
3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Abbott Diagnostics
4.1.2 Roche Diagnostics
4.1.3 Siemens Healthineers
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Cardiac Biomarkers Market Size and Forecast, By Product, 2018-2032 (USD Million)
5.1 Key trends, by product
5.2 Troponins
5.3 Creatine kinase-MB (CK-MB)
5.4 Myoglobin
5.5 Natriuretic peptides
5.6 C-reactive protein (CRP)
5.7 Ischemia modified albumin
5.8 Other products
Chapter 6 Cardiac Biomarkers Market Size and Forecast, By Application, 2018-2032 (USD Million)
6.1 Key trends, by application
6.2 Congestive heart failure
6.3 Myocardial infarction
6.4 Acute coronary syndrome
6.5 Atherosclerosis
6.6 Other applications
Chapter 7 Cardiac Biomarkers Market Size and Forecast, By End-use, 2018-2032 (USD Million)
7.1 Key trends, by end-use
7.2 Hospital laboratory
7.3 Point of care testing facilities
7.4 Diagnostic facilities
7.5 Other end-users
Chapter 8 Cardiac Biomarkers Market Size and Forecast, By Region, 2018-2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Abbott Diagnostics
9.2 Roche Diagnostics
9.3 Siemens Healthineers
9.4 Beckman Coulter
9.5 Bio-Rad Laboratories
9.6 Ortho Clinical Diagnostics
9.7 Randox Laboratories
9.8 Quidel Corporation
9.9 Radiometer
9.10 Tosoh Corporation
9.11 Meso Scale Diagnostics (MSD)
9.12 Thermo Fisher Scientific
9.13 Luminex Corporation
9.14 Trinity Biotech
9.15 Biomerieux
